FDA Inspection
Carter BloodCareCarter BloodCare – FDA Inspection, Jun 14, 2023
Record Details
This FDA Inspection record concerns Carter BloodCare, with an inspection on June 14, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 182c01b4-a170-47d0-9fa0-1467ac05e837
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1210114
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Carter BloodCare
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2024 | Not classified | Dallas District Office | |
| August 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 4, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 5, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare
- FDA Inspection 1257853 - 2024-12-04
- FDA Inspection 1063657 - 2018-08-15
- FDA Inspection 963720 - 2016-01-13
- FDA Inspection 865335 - 2014-02-04
- FDA Inspection 770786 - 2012-03-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.